Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder

Effect of Switching Drug Formulations from Immediate-Release to Extended-Release OROS Methylphenidate

(2009) Josep Antoni Ramos-Quiroga et al.   CNS DRUGS

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

(2009) Michael Rösler et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis

(2009) Ágnes Mészáros et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

(2009) Lenard A. Adler et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

(2008) Rossella Medori et al.   BIOLOGICAL PSYCHIATRY

Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: A two-way crossover study in healthy young adults

(2008) Joseph L Reiz et al.   CLINICAL THERAPEUTICS

Differential Pharmacokinetics and Pharmacodynamics of Methylphenidate Enantiomers

(2008) John S. Markowitz et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder

(2008) M Koesters et al.   JOURNAL OF PSYCHOPHARMACOLOGY